Literature DB >> 22718187

Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

Bruce M Robinson1, Lin Tong, Jinyao Zhang, Robert A Wolfe, David A Goodkin, Roger N Greenwood, Peter G Kerr, Hal Morgenstern, Yun Li, Ronald L Pisoni, Rajiv Saran, Francesca Tentori, Tadao Akizawa, Shunichi Fukuhara, Friedrich K Port.   

Abstract

KDOQI practice guidelines recommend predialysis blood pressure <140/90 mm Hg; however, most prior studies had found elevated mortality with low, not high, systolic blood pressure. This is possibly due to unmeasured confounders affecting systolic blood pressure and mortality. To lessen this bias, we analyzed 24,525 patients by Cox regression models adjusted for patient and facility characteristics. Compared with predialysis systolic blood pressure of 130-159 mm Hg, mortality was 13% higher in facilities with 20% more patients at systolic blood pressure of 110-129 mm Hg and 16% higher in facilities with 20% more patients at systolic blood pressure of ≥160 mm Hg. For patient-level systolic blood pressure, mortality was elevated at low (<130 mm Hg), not high (≥180 mm Hg), systolic blood pressure. For predialysis diastolic blood pressure, mortality was lowest at 60-99 mm Hg, a wide range implying less chance to improve outcomes. Higher mortality at systolic blood pressure of <130 mm Hg is consistent with prior studies and may be due to excessive blood pressure lowering during dialysis. The lowest risk facility systolic blood pressure of 130-159 mm Hg indicates this range may be optimal, but may have been influenced by unmeasured facility practices. While additional study is needed, our findings contrast with KDOQI blood pressure targets, and provide guidance on optimal blood pressure range in the absence of definitive clinical trial data.

Entities:  

Mesh:

Year:  2012        PMID: 22718187      PMCID: PMC3891306          DOI: 10.1038/ki.2012.136

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  44 in total

1.  Combining ecological and individual variables to reduce confounding by indication: case study--subarachnoid hemorrhage treatment.

Authors:  S C Johnston
Journal:  J Clin Epidemiol       Date:  2000-12       Impact factor: 6.437

2.  An introduction to instrumental variables for epidemiologists.

Authors:  S Greenland
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

Review 3.  Selected major risk factors and global and regional burden of disease.

Authors:  Majid Ezzati; Alan D Lopez; Anthony Rodgers; Stephen Vander Hoorn; Christopher J L Murray
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

4.  Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates.

Authors:  S Claiborne Johnston; Tanya Henneman; Charles E McCulloch; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2002-10-15       Impact factor: 4.897

5.  Importance of blood pressure control in hemodialysis patient survival.

Authors:  N Mazzuchi; E Carbonell; J Fernández-Cean
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

6.  Comparative mortality risk of anemia management practices in incident hemodialysis patients.

Authors:  M Alan Brookhart; Sebastian Schneeweiss; Jerry Avorn; Brian D Bradbury; Jun Liu; Wolfgang C Winkelmayer
Journal:  JAMA       Date:  2010-03-03       Impact factor: 56.272

7.  Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference.

Authors:  Nathan W Levin; Peter Kotanko; Kai-Uwe Eckardt; Bertram L Kasiske; Charles Chazot; Alfred K Cheung; Josep Redon; David C Wheeler; Carmine Zoccali; Gérard M London
Journal:  Kidney Int       Date:  2009-12-16       Impact factor: 10.612

8.  Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

Authors:  Giuseppe Mancia; Stéphane Laurent; Enrico Agabiti-Rosei; Ettore Ambrosioni; Michel Burnier; Mark J Caulfield; Renata Cifkova; Denis Clément; Antonio Coca; Anna Dominiczak; Serap Erdine; Robert Fagard; Csaba Farsang; Guido Grassi; Hermann Haller; Anthony Heagerty; Sverre E Kjeldsen; Wolfgang Kiowski; Jean Michel Mallion; Athanasios Manolis; Krzysztof Narkiewicz; Peter Nilsson; Michael H Olsen; Karl Heinz Rahn; Josep Redon; José Rodicio; Luis Ruilope; Roland E Schmieder; Harry A J Struijker-Boudier; Pieter A van Zwieten; Margus Viigimaa; Alberto Zanchetti
Journal:  J Hypertens       Date:  2009-11       Impact factor: 4.844

9.  Rosiglitazone is associated with mortality in chronic hemodialysis patients.

Authors:  Sylvia P B Ramirez; Justin M Albert; Margaret J Blayney; Francesca Tentori; David A Goodkin; Robert A Wolfe; Eric W Young; George R Bailie; Ronald L Pisoni; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 10.121

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  40 in total

1.  Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform.

Authors:  Glenn M Chertow; Jiannong Liu; Keri L Monda; David T Gilbertson; M Alan Brookhart; Anne C Beaubrun; Wolfgang C Winkelmayer; Allan Pollock; Charles A Herzog; Akhtar Ashfaq; Til Sturmer; Kenneth J Rothman; Brian D Bradbury; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2016-02-25       Impact factor: 10.121

2.  Chronic Fluid Overload and Mortality in ESRD.

Authors:  Carmine Zoccali; Ulrich Moissl; Charles Chazot; Francesca Mallamaci; Giovanni Tripepi; Otto Arkossy; Peter Wabel; Stefano Stuard
Journal:  J Am Soc Nephrol       Date:  2017-05-04       Impact factor: 10.121

3.  Reverse Epidemiology of Blood Pressure in Peritoneal Dialysis Associated with Dynamic Deterioration of Left Ventricular Function.

Authors:  Farsad Afshinnia; Ziad S Zaky; Manasa Metireddy; Jonathan H Segal
Journal:  Perit Dial Int       Date:  2015-08-20       Impact factor: 1.756

Review 4.  Blood pressure in hemodialysis: targets?

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-11       Impact factor: 2.894

Review 5.  Blood pressure target for the dialysis patient.

Authors:  Wendy McCallum; Mark J Sarnak
Journal:  Semin Dial       Date:  2018-11-13       Impact factor: 3.455

Review 6.  Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis.

Authors:  Peter Noel Van Buren
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

7.  BP in Dialysis: Results of a Pilot Study.

Authors:  Dana C Miskulin; Jennifer Gassman; Ronald Schrader; Ambreen Gul; Manisha Jhamb; David W Ploth; Lavinia Negrea; Raymond Y Kwong; Andrew S Levey; Ajay K Singh; Antonia Harford; Susan Paine; Cynthia Kendrick; Mahboob Rahman; Philip Zager
Journal:  J Am Soc Nephrol       Date:  2017-12-06       Impact factor: 10.121

Review 8.  Blood Pressure and Mortality in Long-Term Hemodialysis-Time to Move Forward.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Am J Hypertens       Date:  2017-03-01       Impact factor: 2.689

9.  Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS.

Authors:  Manish M Sood; Maria Larkina; Jyothi R Thumma; Francesca Tentori; Brenda W Gillespie; Shunichi Fukuhara; David C Mendelssohn; Kevin Chan; Patricia de Sequera; Paul Komenda; Claudio Rigatto; Bruce M Robinson
Journal:  Kidney Int       Date:  2013-05-15       Impact factor: 10.612

10.  Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients.

Authors:  Ryo Kido; Tadao Akizawa; Masafumi Fukagawa; Yoshihiro Onishi; Takuhiro Yamaguchi; Shunichi Fukuhara
Journal:  Am J Nephrol       Date:  2017-11-21       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.